Patient recovers language and motor function after 19 years
After 19 years in a minimally conscious state, a man recovered language and motor function. Diffusion tensor imaging showed reorganization of the patient's white matter, possibly facilitating functional recovery.
After 19 years in a minimally conscious state, a man recovered language and motor function. Diffusion tensor imaging showed reorganization of the patient's white matter, possibly facilitating functional recovery.
At the initial DTI evaluation by Henning U. Voss, Ph.D., a biomedical researcher at Cornell University, and colleagues, the patient already had regained limited movement, speech, and communication. DTI showed increased anisotropy (less water diffusion in white matter tracts, indicating recovery) in the medial parieto-occipital (MPO) areas compared with controls (J Clin Invest 2006;116:2005-2011).
Eighteen months later, at the time of a second scan, the patient's motor and cognitive functions had further improved. Interestingly, anisotropy in the MPO had decreased. Researchers theorize that the initial increase in anisotropy was a transitional stage of an ongoing axonal sprouting process. Once the new fiber tracts were laid down, anisotropy decreased as axons sprouted toward other targets.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
Adjunctive Brain Volume Quantification Tool for MRI Gets FDA Clearance
November 14th 2023Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative conditions ranging from Alzheimer’s disease to epilepsy.
